DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

Income Statement DaShenLin Pharmaceutical Group Co., Ltd.

Equities

603233

CNE100002RG2

Drug Retailers

End-of-day quote Shanghai S.E. Other stock markets 21/01/2026			5-day change	1st Jan Change
19.58 ^CNY	+0.77%		+5.67%	+11.12%

29/10/25	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
28/08/25	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI

24231f1dd6341d84a68104934b2001b1.fwRwQkLYegZpZtHWFVyOXYeRiHG2UVaHE-5c9stSAz8.SHIHcjW6JVAmMZDvRzb9F8Goxj3jZiT9IaZspo8mcXMSYCAvFJkOawRXug

Published financial data: DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	14.26B	16.29B	21.25B	23.93B	25.86B
Other Revenues, Total	321M	468M	-	600M	636M
Total Revenues	14.58B	16.76B	21.25B	24.53B	26.5B
Cost of Goods Sold, Total	8.99B	10.39B	13.23B	15.8B	17.42B
Gross Profit	5.59B	6.37B	8.02B	8.74B	9.07B
Selling General & Admin Expenses, Total	4.17B	5.19B	6.27B	6.81B	7.42B
Provision for Bad Debts	8.52M	11.49M	23.6M	15.92M	15.28M
R&D Expenses	4.7M	44.61M	74.38M	80.93M	51.68M
Other Operating Expenses	43.74M	29.94M	67.05M	35.32M	35.47M
Other Operating Expenses, Total	4.23B	5.27B	6.43B	6.94B	7.53B
Operating Income	1.36B	1.1B	1.59B	1.8B	1.55B
Interest Expense, Total	-11.5M	-212M	-232M	-239M	-249M
Interest And Investment Income	67.69M	77.7M	68.89M	91.75M	82.23M
Net Interest Expenses	56.19M	-134M	-163M	-148M	-167M
Other Non Operating Income (Expenses)	-26.98M	-29.15M	-48.52M	-49.85M	-46.32M
EBT, Excl. Unusual Items	1.39B	938M	1.38B	1.6B	1.33B
Impairment of Goodwill	-	-	-	-6.21M	-38.6M
Gain (Loss) On Sale Of Investments	2.75M	34.57M	-18.71M	4.38M	10.61M
Gain (Loss) On Sale Of Assets	-2.53M	5.63M	18.73M	3.43M	19.21M
Asset Writedown	-	-	-	-	-
Other Unusual Items	56.8M	65.94M	38.84M	27.05M	13.89M
EBT, Incl. Unusual Items	1.45B	1.04B	1.41B	1.63B	1.34B
Income Tax Expense	363M	240M	336M	397M	360M
Earnings From Continuing Operations	1.08B	804M	1.08B	1.23B	980M
Net Income to Company	1.08B	804M	1.08B	1.23B	980M
Minority Interest	-20.84M	-13.16M	-43.55M	-64.16M	-65.19M
Net Income - (IS)	1.06B	791M	1.04B	1.17B	915M
Net Income to Common Incl Extra Items	1.06B	791M	1.04B	1.17B	915M
Net Income to Common Excl. Extra Items	1.06B	791M	1.04B	1.17B	915M
Per Share Items
Net EPS - Basic	0.94	0.69	0.91	1.03	0.81
Basic EPS - Continuing Operations	0.94	0.69	0.91	1.03	0.81
Basic Weighted Average Shares Outstanding	1.13B	1.14B	1.14B	1.13B	1.13B
Net EPS - Diluted	0.94	0.69	0.91	1.03	0.81
Diluted EPS - Continuing Operations	0.94	0.69	0.91	1.03	0.81
Diluted Weighted Average Shares Outstanding	1.13B	1.14B	1.14B	1.13B	1.13B
Normalized Basic EPS	0.75	0.5	0.72	0.83	0.68
Normalized Diluted EPS	0.75	0.5	0.72	0.83	0.68
Dividend Per Share	0.46	0.35	0.5	0.31	0.62
Payout Ratio	31.38	67.53	40.58	51.82	82.34
Supplemental Items
EBITDA	1.52B	1.3B	1.79B	2.02B	3.13B
EBITA	1.36B	1.11B	1.6B	1.81B	1.57B
EBIT	1.36B	1.1B	1.59B	1.8B	1.55B
EBITDAR	1.53B	1.31B	1.9B	2.09B	3.21B
Total Revenues (As Reported)	14.58B	16.76B	21.25B	24.53B	26.5B
Effective Tax Rate - (Ratio)	25.12	22.94	23.72	24.4	26.85
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	366M	289M	364M	421M	370M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-2.6M	-49.77M	-28M	-23.7M	-10.64M
Normalized Net Income	848M	573M	816M	935M	769M
Interest Capitalized	-	12.7M	18.71M	7.85M	7.17M
Interest on Long-Term Debt	8.23M	225M	233M	224M	52.34M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	30.81M	25.49M
Selling and Marketing Expenses	3.47B	4.27B	5.16B	5.65B	6.22B
General and Administrative Expenses	702M	921M	1.11B	1.15B	1.21B
Research And Development Expense From Footnotes	7.15M	48.2M	78.41M	87.6M	51.68M
Net Rental Expense, Total	7.65M	11.26M	112M	73.78M	80.17M
Imputed Operating Lease Interest Expense	815K	6.07M	40.16M	23.45M	23.04M
Imputed Operating Lease Depreciation	6.84M	5.19M	72.05M	50.33M	57.13M
Stock-Based Comp., G&A Exp. (Total)	14.45M	65.63M	40.3M	19.04M	3.44M
Total Stock-Based Compensation	14.45M	65.63M	40.3M	19.04M	3.44M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.75B	2.79B	4.49B	4.42B	6.22B
Short Term Investments	200M	-	-	-	6M
Trading Asset Securities, Total	690M	109M	91.99M	41.99M	15.51M
Total Cash And Short Term Investments	4.64B	2.9B	4.59B	4.46B	6.24B
Accounts Receivable, Total	432M	744M	1.02B	1.23B	1.3B
Other Receivables	268M	366M	368M	437M	400M
Total Receivables	700M	1.11B	1.39B	1.67B	1.7B
Inventory	2.68B	3.63B	3.87B	4.18B	4.13B
Prepaid Expenses	161M	2.41M	39.03M	11.97M	24.75M
Other Current Assets, Total	113M	224M	783M	476M	492M
Total Current Assets	8.3B	7.87B	10.67B	10.8B	12.59B
Gross Property Plant And Equipment	1.88B	8.85B	9.8B	11.56B	12.1B
Accumulated Depreciation	-597M	-3.2B	-3.71B	-4.26B	-4.8B
Net Property Plant And Equipment	1.29B	5.65B	6.09B	7.3B	7.31B
Long-term Investments	150M	150M	132M	156M	156M
Goodwill	1.33B	2.06B	2.36B	3.02B	3.52B
Other Intangibles, Total	490M	619M	637M	1.86B	1.97B
Deferred Tax Assets Long-Term	41.53M	158M	186M	214M	232M
Deferred Charges Long-Term	572M	670M	663M	670M	648M
Other Long-Term Assets, Total	160M	158M	94.19M	101M	22.22M
Total Assets	12.33B	17.34B	20.84B	24.12B	26.44B
Liabilities
Accounts Payable, Total	4.21B	4.74B	6.13B	6.87B	8.43B
Accrued Expenses, Total	448M	489M	810M	758M	686M
Short-term Borrowings	191M	165M	697M	745M	1.98B
Current Portion of Long-Term Debt	1.04M	-	7.64M	14.84M	42.28M
Current Portion of Leases	-	906M	975M	1.04B	1.18B
Current Income Taxes Payable	136M	98.67M	138M	176M	138M
Unearned Revenue Current, Total	68.11M	164M	436M	362M	409M
Other Current Liabilities	410M	615M	517M	1.49B	840M
Total Current Liabilities	5.47B	7.18B	9.71B	11.45B	13.71B
Long-Term Debt	1.21B	1.25B	1.46B	1.64B	1.85B
Long-Term Leases	-	2.95B	2.79B	3.07B	2.7B
Unearned Revenue Non Current	83.27M	20.12M	17.64M	19.3M	17.42M
Other Non Current Liabilities	-	-	328K	9.67M	34.84M
Total Liabilities	6.76B	11.4B	13.98B	16.19B	18.3B
Common Stock, Total	659M	791M	949M	1.14B	1.14B
Additional Paid In Capital	1.76B	1.64B	1.54B	1.35B	1.29B
Retained Earnings	2.87B	2.93B	3.57B	4.17B	4.38B
Treasury Stock	-99.41M	-77.59M	-36.68M	-29.72M	-101M
Comprehensive Income and Other	190M	190M	190M	190M	190M
Total Common Equity	5.38B	5.48B	6.21B	6.82B	6.9B
Minority Interest	188M	457M	652M	1.11B	1.24B
Total Equity	5.57B	5.94B	6.86B	7.93B	8.14B
Total Liabilities And Equity	12.33B	17.34B	20.84B	24.12B	26.44B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.14B	1.14B	1.14B	1.14B	1.14B
ECS Total Common Shares Outstanding	1.14B	1.14B	1.14B	1.14B	1.14B
Book Value / Share	4.73	4.81	5.45	5.99	6.06
Tangible Book Value	3.56B	2.8B	3.21B	1.94B	1.41B
Tangible Book Value Per Share	3.13	2.46	2.82	1.7	1.23
Total Debt	1.4B	5.28B	5.93B	6.51B	7.74B
Net Debt	-3.24B	2.37B	1.35B	2.05B	1.51B
Debt Equivalent Oper. Leases	61.24M	90.08M	898M	590M	641M
Minority Interest, Total (Incl. Fin. Div)	188M	457M	652M	1.11B	1.24B
Equity Method Investments, Total	320K	188K	142K	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	91.56M	164M	163M	178M	96.3M
Inventories - Work In Process, Total	23.35M	34.11M	38.01M	31.05M	50.77M
Inventories - Finished Goods, Total	2.58B	3.45B	3.68B	3.98B	3.97B
Inventories - Others	-	-	-	61.98M	35.08M
Buildings, Total	775M	800M	1.08B	2.02B	2.66B
Machinery, Total	938M	1.12B	1.26B	1.46B	1.6B
Full Time Employees	32.34K	38.35K	39.5K	45.47K	43.53K
Accumulated Allowance for Doubtful Accounts (Supple)	28.93M	45.22M	59.89M	72.43M	76.96M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.06B	791M	1.04B	1.17B	915M
Depreciation & Amortization - CF	160M	1.13B	1.26B	1.41B	1.56B
Amortization of Goodwill and Intangible Assets - (CF)	4.37M	9.58M	10.3M	18.38M	23.58M
Depreciation & Amortization, Total	164M	1.14B	1.27B	1.43B	1.58B
Amortization of Deferred Charges, Total - (CF)	176M	228M	260M	267M	311M
(Gain) Loss From Sale Of Asset	2.53M	-5.63M	-18.73M	-3.43M	-19.21M
(Gain) Loss on Sale of Investments - (CF)	-20.91M	-44M	12.89M	-10.94M	-11.57M
Asset Writedown & Restructuring Costs	-	-	-	6.21M	38.6M
Provision and Write-off of Bad Debts	8.52M	11.49M	23.6M	15.92M	15.28M
Other Operating Activities, Total	52.1M	247M	294M	388M	348M
Change In Accounts Receivable	-75.05M	-318M	-953M	-365M	-1.59B
Change In Inventories	-540M	-746M	-157M	-104M	126M
Change In Accounts Payable	1.11B	235M	1.97B	389M	1.4B
Change In Deferred Taxes	-2.6M	-49.74M	-28M	-23.7M	-10.64M
Change in Other Net Operating Assets	14.45M	65.63M	48.54M	19.04M	3.28M
Cash from Operations	1.95B	1.55B	3.76B	3.17B	3.11B
Capital Expenditure	-792M	-1.29B	-1.03B	-1.8B	-1.48B
Sale of Property, Plant, and Equipment	12.35M	21.61M	37.37M	14.64M	28.53M
Cash Acquisitions	-290M	-530M	-305M	-502M	-521M
Divestitures	-	-	-	-	1.59M
Investment in Marketable and Equity Securities, Total	-19.16M	814M	5.54M	-2.16M	11.34M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-5M	-
Other Investing Activities, Total	17.64M	21.35M	3.17M	-11.8M	15.86M
Cash from Investing	-1.07B	-968M	-1.29B	-2.3B	-1.94B
Short Term Debt Issued, Total	-	146M	-	16M	192M
Long-Term Debt Issued, Total	1.57B	-	1.1B	1.09B	3.14B
Total Debt Issued	1.57B	146M	1.1B	1.11B	3.33B
Short Term Debt Repaid, Total	-	-223M	-	-4.9M	-
Long-Term Debt Repaid, Total	-119M	-1.1B	-1.66B	-2.39B	-3.42B
Total Debt Repaid	-119M	-1.32B	-1.66B	-2.39B	-3.42B
Issuance of Common Stock	100M	13.25M	-	-	-
Repurchase of Common Stock	-	-436K	-110K	-946K	-102M
Common Dividends Paid	-333M	-534M	-420M	-605M	-753M
Common & Preferred Stock Dividends Paid	-333M	-534M	-420M	-605M	-753M
Other Financing Activities, Total	-8.41M	84.37M	46.98M	238M	15.52M
Cash from Financing	1.21B	-1.61B	-934M	-1.65B	-932M
Foreign Exchange Rate Adjustments	-	-	-	-	320K
Net Change in Cash	2.09B	-1.02B	1.53B	-779M	235M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	847M	898M	939M	1.11B	1.27B
Levered Free Cash Flow	939M	413M	2.19B	2.26B	2.08B
Unlevered Free Cash Flow	946M	545M	2.33B	2.41B	2.23B
Change In Net Working Capital	-534M	281M	-805M	-1.37B	-844M
Net Debt Issued / Repaid	1.45B	-1.17B	-560M	-1.28B	-92.44M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.09	4.64	5.2	4.99	3.83
Return on Total Capital	14.62	7.57	8.27	8.24	6.38
Return On Equity %	21.87	13.98	16.86	16.63	12.19
Return on Common Equity	22.07	14.57	17.72	17.9	13.33
Margin Analysis
Gross Profit Margin %	38.33	38.03	37.76	35.61	34.25
SG&A Margin	28.61	30.95	29.51	27.75	28.02
EBITDA Margin %	10.45	7.73	8.42	8.22	11.82
EBITA Margin %	9.36	6.63	7.52	7.4	5.93
EBIT Margin %	9.33	6.57	7.47	7.32	5.84
Income From Continuing Operations Margin %	7.43	4.8	5.08	5.02	3.7
Net Income Margin %	7.28	4.72	4.87	4.76	3.45
Net Avail. For Common Margin %	7.28	4.72	4.87	4.76	3.45
Normalized Net Income Margin	5.81	3.42	3.84	3.81	2.9
Levered Free Cash Flow Margin	6.44	2.46	10.3	9.22	7.84
Unlevered Free Cash Flow Margin	6.49	3.25	10.99	9.83	8.43
Asset Turnover
Asset Turnover	1.39	1.13	1.11	1.09	1.05
Fixed Assets Turnover	12.12	4.83	3.62	3.66	3.63
Receivables Turnover (Average Receivables)	36.2	27.7	24.07	21.22	20.39
Inventory Turnover (Average Inventory)	3.8	3.29	3.53	3.92	4.19
Short Term Liquidity
Current Ratio	1.52	1.1	1.1	0.94	0.92
Quick Ratio	0.98	0.56	0.62	0.54	0.58
Operating Cash Flow to Current Liabilities	0.36	0.22	0.39	0.28	0.23
Days Sales Outstanding (Average Receivables)	10.11	13.18	15.17	17.2	17.95
Days Outstanding Inventory (Average Inventory)	96.4	110.93	103.53	93.05	87.28
Average Days Payable Outstanding	141.03	144.17	147.23	147.3	161.24
Cash Conversion Cycle (Average Days)	-34.52	-20.06	-28.54	-37.04	-56.01
Long Term Solvency
Total Debt/Equity	25.11	88.87	86.41	82.04	95.16
Total Debt / Total Capital	20.07	47.05	46.35	45.07	48.76
LT Debt/Equity	21.66	70.82	61.94	59.34	55.82
Long-Term Debt / Total Capital	17.32	37.5	33.23	32.6	28.6
Total Liabilities / Total Assets	54.81	65.76	67.06	67.11	69.22
EBIT / Interest Expense	118.3	5.19	6.84	7.51	6.22
EBITDA / Interest Expense	132.59	10.57	12.33	13.48	12.58
(EBITDA - Capex) / Interest Expense	63.68	4.46	7.87	5.97	6.65
Total Debt / EBITDA	0.92	2.35	2.07	2.02	2.47
Net Debt / EBITDA	-2.13	1.06	0.47	0.64	0.48
Total Debt / (EBITDA - Capex)	1.91	5.58	3.25	4.56	4.68
Net Debt / (EBITDA - Capex)	-4.43	2.51	0.74	1.44	0.91
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	30.89	14.92	26.78	15.45	8.01
Gross Profit, 1 Yr. Growth %	27.36	14.03	25.86	8.9	3.87
EBITDA, 1 Yr. Growth %	43.97	-15.49	37.05	11.52	-3.49
EBITA, 1 Yr. Growth %	46.96	-19.12	42.56	12.28	-14.33
EBIT, 1 Yr. Growth %	48.45	-19.18	44.16	12.98	-13.86
Earnings From Cont. Operations, 1 Yr. Growth %	55.48	-25.73	34.17	14.03	-20.37
Net Income, 1 Yr. Growth %	51.17	-25.51	30.9	12.63	-21.58
Normalized Net Income, 1 Yr. Growth %	48.71	-32.37	42.51	14.34	-17.79
Diluted EPS Before Extra, 1 Yr. Growth %	47.27	-25.93	29.76	13.19	-21.36
Accounts Receivable, 1 Yr. Growth %	21.54	72.05	37.37	20.77	5.61
Inventory, 1 Yr. Growth %	30.53	35.33	6.68	7.97	-1.27
Net Property, Plant and Equip., 1 Yr. Growth %	15.01	339.24	7.8	19.79	0.06
Total Assets, 1 Yr. Growth %	42.21	40.58	20.22	15.75	9.6
Tangible Book Value, 1 Yr. Growth %	22.62	-21.37	14.68	-39.55	-27.55
Common Equity, 1 Yr. Growth %	27	1.74	13.38	9.85	1.08
Cash From Operations, 1 Yr. Growth %	14.41	-20.42	141.58	-15.51	-2.13
Capital Expenditures, 1 Yr. Growth %	58.02	63.44	-20.09	73.62	-17.86
Levered Free Cash Flow, 1 Yr. Growth %	-10.78	-44.26	430.76	3.2	-8.09
Unlevered Free Cash Flow, 1 Yr. Growth %	-11.78	-27.06	328.31	3.19	-7.34
Dividend Per Share, 1 Yr. Growth %	60.04	-25.01	43.97	-38	100
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.3	22.65	20.71	20.99	11.67
Gross Profit, 2 Yr. CAGR %	23.2	20.51	19.8	17.07	6.36
EBITDA, 2 Yr. CAGR %	35.42	10.62	8.04	24.26	31.59
EBITA, 2 Yr. CAGR %	37.22	9.38	7.86	27.25	-1.41
EBIT, 2 Yr. CAGR %	38	9.63	7.94	27.72	-1.35
Earnings From Cont. Operations, 2 Yr. CAGR %	43.53	7.46	-0.17	23.69	-4.71
Net Income, 2 Yr. CAGR %	41.35	6.12	-1.25	21.42	-6.02
Normalized Net Income, 2 Yr. CAGR %	37.73	0.26	-1.83	27.77	-3.05
Diluted EPS Before Extra, 2 Yr. CAGR %	38.05	4.44	-1.57	21.3	-5.65
Accounts Receivable, 2 Yr. CAGR %	23.74	44.61	53.74	28.8	12.93
Inventory, 2 Yr. CAGR %	19.26	32.91	20.15	7.32	3.25
Net Property, Plant and Equip., 2 Yr. CAGR %	14.42	124.76	117.61	13.64	9.48
Total Assets, 2 Yr. CAGR %	37.35	41.39	30	17.96	12.63
Tangible Book Value, 2 Yr. CAGR %	26.22	-1.81	-5.04	-16.74	-33.82
Common Equity, 2 Yr. CAGR %	33.13	13.67	7.41	11.6	5.37
Cash From Operations, 2 Yr. CAGR %	49.55	-4.58	38.66	42.87	-9.07
Capital Expenditures, 2 Yr. CAGR %	19.55	60.71	14.28	17.79	19.42
Levered Free Cash Flow, 2 Yr. CAGR %	70.71	-37.39	72	134.12	-2.61
Unlevered Free Cash Flow, 2 Yr. CAGR %	67.52	-28.71	76.75	110.31	-2.22
Dividend Per Share, 2 Yr. CAGR %	44.22	9.55	3.92	-5.52	11.36
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	25.25	23.68	24.01	18.93	16.5
Gross Profit, 3 Yr. CAGR %	23.35	20.06	22.27	16.05	12.5
EBITDA, 3 Yr. CAGR %	27.95	15.95	19.12	9.56	33.84
EBITA, 3 Yr. CAGR %	27.63	15.3	19.84	9.74	11.91
EBIT, 3 Yr. CAGR %	27.91	15.53	20.11	9.65	12.01
Earnings From Cont. Operations, 3 Yr. CAGR %	31.65	15.23	15.72	4.35	6.8
Net Income, 3 Yr. CAGR %	30.77	14.17	13.81	3.17	4.95
Normalized Net Income, 3 Yr. CAGR %	29.02	8.64	12.73	3.35	10.3
Diluted EPS Before Extra, 3 Yr. CAGR %	26.11	12.18	12.58	3.19	4.99
Accounts Receivable, 3 Yr. CAGR %	20.58	38.11	42.16	41.85	20.55
Inventory, 3 Yr. CAGR %	16.04	24.39	23.52	15.95	4.38
Net Property, Plant and Equip., 3 Yr. CAGR %	17.1	79.16	75.94	78.34	8.92
Total Assets, 3 Yr. CAGR %	28.42	38.42	33.95	25.06	15.11
Tangible Book Value, 3 Yr. CAGR %	12.86	7.8	3.4	-18.31	-20.51
Common Equity, 3 Yr. CAGR %	25.06	21.72	13.58	8.21	7.98
Cash From Operations, 3 Yr. CAGR %	44.48	21.19	30.05	17.55	25.94
Capital Expenditures, 3 Yr. CAGR %	5.83	32.68	27.32	31.38	4.45
Levered Free Cash Flow, 3 Yr. CAGR %	387.57	8.58	27.66	45.11	71.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	264.31	17.36	29.6	47.76	60.03
Dividend Per Share, 3 Yr. CAGR %	27.65	15.97	20.01	-12.52	21.31
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.6	21.72	23.42	22.59	18.92
Gross Profit, 5 Yr. CAGR %	20.94	20.39	21.91	18.86	15.64
EBITDA, 5 Yr. CAGR %	-	14.4	19.72	19.39	24.21
EBITA, 5 Yr. CAGR %	18.69	12.69	19.48	20.15	11.09
EBIT, 5 Yr. CAGR %	18.61	12.68	19.55	20.26	11.05
Earnings From Cont. Operations, 5 Yr. CAGR %	20.73	13.42	17.86	18.54	7.07
Net Income, 5 Yr. CAGR %	21.85	12.96	16.87	17.02	5.42
Normalized Net Income, 5 Yr. CAGR %	21.72	9.5	15.65	15.92	6.17
Diluted EPS Before Extra, 5 Yr. CAGR %	15.49	9.49	14.21	15.93	4.94
Accounts Receivable, 5 Yr. CAGR %	31.27	29.18	32.89	34.31	29.66
Inventory, 5 Yr. CAGR %	21.18	22.71	17.67	17.26	14.97
Net Property, Plant and Equip., 5 Yr. CAGR %	18.47	55.33	50.04	49.33	45.53
Total Assets, 5 Yr. CAGR %	35.92	37.09	29.05	29.84	24.98
Tangible Book Value, 5 Yr. CAGR %	30.44	20.02	5.33	-2.78	-13.5
Common Equity, 5 Yr. CAGR %	39.45	32.98	17.68	17.57	10.22
Cash From Operations, 5 Yr. CAGR %	33.05	25.7	42.12	29.43	12.71
Capital Expenditures, 5 Yr. CAGR %	26.17	33.33	9.13	26.51	24.1
Levered Free Cash Flow, 5 Yr. CAGR %	437.54	17.16	206.44	47.65	14.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	148.13	22.81	160.21	48.2	15.8
Dividend Per Share, 5 Yr. CAGR %	2.97	-	17.57	6.85	16.47